No Data
No Data
Mizuho Securities Maintains EyePoint Pharmaceuticals(EYPT.US) With Buy Rating, Announces Target Price $30
Li Auto, Xponential Fitness And Other Big Stocks Moving Lower In Friday's Pre-Market Session
TD Cowen Maintains EyePoint Pharmaceuticals(EYPT.US) With Buy Rating, Maintains Target Price $20
Analysts Offer Insights on Healthcare Companies: OnKure Therapeutics (OKUR) and EyePoint Pharmaceuticals (EYPT)
JonesTrading Maintains EyePoint Pharmaceuticals(EYPT.US) With Buy Rating, Cuts Target Price to $42
EyePoint Pharmaceuticals Is Maintained at Buy by Chardan Capital